Clinical trials
Recruiting Leukemia, Biphenotypic, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 9 |
| M.D. Anderson Cancer Center | 4 |
| St. Jude Children's Research Hospital | 3 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2 |
| Orca Biosystems, Inc. | 2 |
| St. Petersburg State Pavlov Medical University | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| AVM Biotechnology Inc | 1 |
| Andrew E. Place, MD | 1 |
| Children's Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Biphenotypic, Acute | 47 |
| Leukemia, Myeloid, Acute | 32 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 26 |
| Myelodysplastic Syndromes | 21 |
| Leukemia, Myelomonocytic, Chronic | 11 |
| Leukemia | 10 |
| Burkitt Lymphoma | 8 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
Trials
Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.